GUJARAT THEMIS BIOSYN
|
GUJARAT THEMIS BIOSYN Last 5 Year Financial Ratios History
[Standalone]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Operational & Financial Ratios | |||||
Earnings Per Share (Rs) | 39.90 | 30.03 | 20.77 | 16.30 | 4.41 |
CEPS(Rs) | 41.67 | 31.56 | 21.96 | 17.23 | 5.25 |
DPS(Rs) | 5.40 | 11.00 | - | 1.65 | - |
Book NAV/Share(Rs) | 102.66 | 71.11 | 48.14 | 29.04 | 12.75 |
Tax Rate(%) | 25.17 | 26.10 | 26.18 | 24.26 | 21.80 |
Margin Ratios | |||||
Core EBITDA Margin(%) | 49.82 | 50.54 | 44.53 | 37.40 | 17.93 |
EBIT Margin(%) | 52.13 | 52.12 | 46.23 | 37.80 | 20.35 |
Pre Tax Margin(%) | 52.00 | 51.40 | 45.14 | 36.72 | 19.96 |
PAT Margin (%) | 38.91 | 37.98 | 33.32 | 27.81 | 15.61 |
Cash Profit Margin (%) | 40.64 | 39.93 | 35.24 | 29.41 | 18.59 |
Performance Ratios | |||||
ROA(%) | 35.81 | 37.08 | 35.65 | 45.62 | 24.07 |
ROE(%) | 45.92 | 50.35 | 53.82 | 77.99 | 41.85 |
ROCE(%) | 61.53 | 67.91 | 67.89 | 85.96 | 44.88 |
Asset Turnover(x) | 0.92 | 0.98 | 1.07 | 1.64 | 1.54 |
Sales/Fixed Asset(x) | 4.12 | 4.27 | 3.82 | 4.25 | 2.65 |
Working Capital/Sales(x) | 3.27 | 1.88 | 1.91 | 7.22 | -8.60 |
Efficiency Ratios | |||||
Fixed Capital/Sales(x) | 0.24 | 0.23 | 0.26 | 0.24 | 0.38 |
Receivable days | 52.71 | 63.29 | 70.42 | 55.80 | 37.88 |
Inventory Days | 32.13 | 28.06 | 24.34 | 13.65 | 3.55 |
Payable days | 114.42 | 115.10 | 132.50 | 215.31 | 1,966.91 |
Valuation Parameters | |||||
PER(x) | 17.20 | 13.57 | 9.80 | 5.96 | 8.91 |
PCE(x) | 16.47 | 12.91 | 9.27 | 5.64 | 7.48 |
Price/Book(x) | 6.69 | 5.73 | 4.23 | 3.35 | 3.08 |
Yield(%) | 0.79 | 2.70 | - | 1.70 | - |
EV/Net Sales(x) | 6.63 | 5.05 | 3.00 | 1.73 | 1.50 |
EV/Core EBITDA(x) | 12.31 | 9.33 | 6.22 | 4.39 | 6.41 |
EV/EBIT(x) | 12.72 | 9.68 | 6.48 | 4.58 | 7.35 |
EV/CE(x) | 5.29 | 4.23 | 2.76 | 2.07 | 1.87 |
M Cap / Sales | 6.69 | 5.15 | 3.27 | 1.66 | 1.39 |
Growth Ratio | |||||
Net Sales Growth(%) | 29.71 | 26.82 | 6.39 | 107.37 | 5.80 |
Core EBITDA Growth(%) | 29.22 | 42.43 | 29.97 | 250.30 | 49.51 |
EBIT Growth(%) | 29.74 | 42.99 | 30.09 | 285.20 | 58.95 |
PAT Growth(%) | 32.88 | 44.55 | 27.48 | 269.40 | 65.73 |
EPS Growth(%) | 32.88 | 44.55 | 27.47 | 269.40 | 65.73 |
Financial Stability Ratios | |||||
Total Debt/Equity(x) | - | - | 0.04 | 0.19 | 0.32 |
Current Ratio(x) | 2.28 | 2.93 | 2.84 | 1.49 | 0.63 |
Quick Ratio(x) | 1.87 | 2.57 | 2.60 | 1.24 | 0.60 |
Interest Cover(x) | 386.97 | 72.31 | 42.66 | 34.85 | 52.71 |
Total Debt/Mcap(x) | - | - | 0.01 | 0.06 | 0.11 |
Compare Financial Ratios of peers of GUJARAT THEMIS BIOSYN
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GUJARAT THEMIS BIOSYN | ₹2,975.9 Cr | -1% | 7% | 151% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹367,290.0 Cr | -0.9% | 0.9% | 62.6% | Stock Analytics | |
CIPLA | ₹113,357.0 Cr | 3.5% | 4.2% | 51.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹111,134.0 Cr | 12.2% | 18% | 103.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹104,235.0 Cr | 0.8% | 5.6% | 19.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,001.5 Cr | -1% | -2.4% | 28.4% | Stock Analytics |
GUJARAT THEMIS BIOSYN Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GUJARAT THEMIS BIOSYN | -1% |
7% |
151% |
SENSEX | 1.7% |
1.5% |
18.7% |
You may also like the below Video Courses